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ARTICLE
Extracellular bacterial lymphatic metastasis drives
Streptococcus pyogenes systemic infection
Matthew K. Siggins 1,2,5✉, Nicola N. Lynskey1,2,6, Lucy E. Lamb1, Louise A. Johnson3, Kristin K. Huse1,2,
Max Pearson 1,2, Suneale Banerji3, Claire E. Turner1,7, Kevin Woollard 4, David G. Jackson 3 &
Shiranee Sriskandan 1,2✉
Unassisted metastasis through the lymphatic system is a mechanism of dissemination thus
far ascribed only to cancer cells. Here, we report that Streptococcus pyogenes also hijack
lymphatic vessels to escape a local infection site, transiting through sequential lymph nodes
and efferent lymphatic vessels to enter the bloodstream. Contrasting with previously
reported mechanisms of intracellular pathogen carriage by phagocytes, we show S. pyogenes
remain extracellular during transit, first in afferent and then efferent lymphatics that carry the
bacteria through successive draining lymph nodes. We identify streptococcal virulence
mechanisms important for bacterial lymphatic dissemination and show that metastatic
streptococci within infected lymph nodes resist and subvert clearance by phagocytes,
enabling replication that can seed intense bloodstream infection. The findings establish the
lymphatic system as both a survival niche and conduit to the bloodstream for S. pyogenes,
explaining the phenomenon of occult bacteraemia. This work provides new perspectives in
streptococcal pathogenesis with implications for immunity.
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Lymphatic vessels form an extensive, tissue-permeating net-work around the body that carries fluid from interstitialspaces, through lymph nodes, and back to the blood circu-
lation. Initial lymphatics have distinctive loose junctions that
allow selective passage of leucocytes, fluids and small macro-
molecules but could in principle also provide an ideal conduit for
the dissemination of pathogens1,2. However, in addition to their
well-recognised importance in adaptive immunity, lymph nodes
are reported to efficiently filter microbes3,4 and orchestrate innate
immune responses that contain and kill pathogens to limit sys-
temic dissemination5. Hence, lymphatic metastasis—the spread of
a pathogenic agent from an initial to a secondary site via the
lymphatics—is only considered to contribute meaningfully to the
pathogenesis of some cancers6,7 and a few specialised intracellular
lymph-tropic pathogens, such as Yersinia pestis which can be
carried through the lymphatics inside phagocytic cells8. The
human pathogen Streptococcus pyogenes (group A streptococcus)
is widely recognised to interact with the lymphatic system pre-
senting clinical manifestations such as lymphadenitis and lym-
phangitis9–11. We recently provided a possible explanation for
this tropism, by demonstrating that the hyaluronan capsule of S.
pyogenes binds LYVE-1 (lymphatic vessel endothelial receptor),
the hyaluronan receptor that mediates leukocyte entry to initial
lymphatic vessels12,13.
S. pyogenes is a major infectious cause of global human mor-
tality14 and the leading bacterial cause of tonsillitis and cellulitis.
Invasive streptococcal infection, albeit rare, is particularly
devastating, with case-fatality rates of up to 25%14,15. One fifth of
invasive S. pyogenes infections present as bloodstream infection
without any obvious point of origin16,17, and almost half of
invasive streptococcal necrotising soft tissue infections lack any
clear portal of entry18–20. It has been postulated that S. pyogenes
emanates from a mucosal site of colonisation or infection to seed
soft tissue infection via the bloodstream, although this has been
neither demonstrated nor the mechanism of entry to the blood-
stream elucidated21,22. We hypothesised that S. pyogenes tropism
for the lymphatic system is important in such occult infections.
Here we show that virulent S. pyogenes not only reach the first
local draining lymph node, as demonstrated previously12, but
readily transit through sequential lymph nodes within efferent
lymphatics to reach the bloodstream, while remaining extra-
cellular. This lymphatic metastasis is a key pathway of dis-
semination that can drive bloodstream infection.
Results
S. pyogenes access systemic circulation via lymphatics. Based on
the lymphatic pathology associated with S. pyogenes disease and
our recent discovery that the hyaluronan capsule of S. pyogenes
binds the lymphatic endothelial hyaluronan receptor LYVE-
112,23, we hypothesised that the lymphatic system plays a central
role in streptococcal pathogenesis in invasive infection. To
investigate this, we first systematically studied lymphatic invol-
vement in bacterial dissemination using an established murine
model of S. pyogenes soft tissue invasion24. Following intramus-
cular infection, we quantified bacterial burden in systemic organs,
all lymph nodes that drain the hindlimb, and nodes that do not
drain this injection site (Supplementary Fig. 1). Within 0.5 h,
mice infected with S. pyogenes invasive M1T1 clinical isolate
H598 (Supplementary Table 1) had significant numbers of viable
S. pyogenes in not only the local draining inguinal lymph node
but also the sequential distant-draining ipsilateral axillary lymph
node. In contrast, no bacteria were in any non-draining lymph
nodes, and few bacteria were recovered from blood or systemic
organs (Fig. 1a). These observations pointed to a fundamentally
distinct route of dissemination for extracellular bacteria, involving
not only transit via draining afferent lymphatics to a local
draining lymph node, but also subsequent transit through efferent
postnodal lymphatics in order to reach sequential distant drain-
ing lymph nodes. 3 h after infection, bacterial numbers in local
and distant draining lymph nodes had increased 25-fold, whereas
non-draining lymph nodes remained clear of bacteria (Fig. 1b).
Draining lymph finally enters the bloodstream via the lymphatic
ducts, and the surge in lymphatic bacterial burden at 3 h was
accompanied by a similar surge in spleen bacterial load, an organ
which removes bacteria from blood, providing clear evidence of S.
pyogenes entry into the bloodstream25. 24 h post-infection, bac-
teraemia had increased from <10 CFU/ml to ≥106 CFU/ml and a
high bacterial burden was identified in all organs (Fig. 1c, d)
including both draining and non-draining lymph nodes, con-
sistent with blood-borne systemic spread. Significantly, bacterial
counts within the infection site in the hindlimb remained con-
stant throughout the infection time course, suggesting that the
lymphatic dissemination and metastatic expansion of bacteria was
driving development of intense bloodstream infection.
To determine if transit through the draining inguinal lymph
node was required for bacteria to reach the sequential distant
draining axillary node, the local draining inguinal lymph node was
excised prior to hindlimb infection. This lymphadenectomy
abrogated bacterial dissemination to the axillary lymph node
(Fig. 1e), providing clear confirmation that transit of bacteria from
the infection site to distant lymph nodes occurred via sequential
lymph nodes (Fig. 1f). Importantly, a range of different S. pyogenes
clinical isolates exhibited bacterial dissemination via the lymphatic
system across different phases of bacterial growth and within
FVB/n, BALB/c, and C57BL/6 mouse strains (Supplementary
Fig. 2a, b), implying broad significance to streptococcal infection.
Notably, lymphatic dissemination occurred with a range of
infection titres (Supplementary Fig. 2c), including bacterial
densities similar to those encountered in human tissues during
S. pyogenes infection26, underlining the relevance of our findings
to human disease.
S. pyogenes transit to and between lymph nodes in lymphatic
vessels. Next, to unequivocally confirm the route of bacterial
transit between lymph nodes, we directly monitored the efferent
vasculature that runs from the inguinal to the axillary lymph node
using intravital confocal microscopy and a hypervirulent in vivo-
passaged M1T1 strain (H1565) that displayed prominent lym-
phatic dissemination (Fig. 2a–c and Supplementary Fig. 3a–c and
Supplementary Movie 1). Within 1 h of injection into the hin-
dlimb, fluorescent S. pyogenes (Fig. 2d) were present inside
postnodal efferent lymphatic vessels that transport lymph from
the inguinal to the axillary node but were absent from blood
vessels and surrounding tissue (Fig. 2e). Intraluminal bacteria
appeared to be either suspended in lymph flow or bound to
lymphatic endothelial surfaces (Fig. 2f, g and Supplementary
Movies 2 and 3). In some lymphatic vessels, we observed strep-
tococci in close association with leucocytes, although careful
analysis revealed these were not intracellular but rather attached
to the leucocyte cell surface in characteristic small chains (Fig. 2h,
i, and Supplementary Movies 4 and 5). Moreover, phenotypic
analyses indicated most leucocytes within the efferent lymphatic
vessel were CD3+ T cells with only small numbers of CD11b+
phagocytes being present (Supplementary Data Fig. 3h, i).
Tumour cells, which also can transit through sequential lymph
nodes to reach the blood27, have recently been reported to
intravasate lymph node blood vessels to access the systemic
circulation directly from within lymph nodes28,29. To ascertain
whether bacteria were invading lymph node blood vessels to
reach the systemic circulation or remained predominantly within
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Fig. 1 S. pyogenes access systemic circulation via lymphatics. a–c S. pyogenes (H598) recovered from the hindlimb infection site, lymph nodes, and systemic
organs of FVB/n mice 0.5 h (blue circles, a), 3 h (red circles, b), or 24 h (grey circles, c) after intramuscular infection with 108 CFU. Symbols represent individual
mice, n= 6 per group, lines indicate geometric means. d Schematic summarising representative time course of transit of S. pyogenes from the hindlimb following
intramuscular injection of hypervirulent S. pyogenes, organs listed in f. Black indicates 0 CFU; grey, low CFU; and red, high CFU counts. e Recovery of S. pyogenes
from hindlimb infection site and ipsilateral axillary lymph nodes 1 h after intramuscular infection with 108 CFU in FVB/n mice, with (red bars or red circles) or
without (blue bars) surgical removal of the draining ipsilateral inguinal lymph node prior to infection. Symbols represent individual mice, n= 4 per group, bars
indicate geometric means. ****p≤0.0001; ns, p > 0.5: Two-tailed Student’s t-test performed on log10-transformed data. f Schematic of lymphatic drainage route
from hindlimb following intramuscular injection of Evans Blue dye, indicated by blue arrows and colouring: ig, ipsilateral inguinal node; il, ipsilateral iliac node; ax,
ipsilateral axillary node; and ht, heart (via subclavian vein); br, ipsilateral (non-draining) brachial node. See also Supplementary Figs. 1 and 2. CFU are per ml of
blood, per g of liver, per leg, or per organ.
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the lymph node sinuses, we assessed the position of S. pyogenes
within draining lymph nodes 3 h after infection with the
hypervirulent strain H1565 using immunofluorescence micro-
scopy. In both ipsilateral inguinal lymph nodes (local draining)
(Fig. 3a–d and Supplementary Movie 6) and ipsilateral axillary
lymph nodes (distant draining) (Fig. 3e–h and Supplementary
Movie 7), bacteria accumulated in the subcapsular (Fig. 3b, f) and
medullary sinuses (Fig. 3c, g), consistent with entry and exit of
bacteria between sequential lymph nodes via the lymphatics. In
contrast, very few streptococci were observed to have exited to the
lymph node parenchyma (Fig. 3d, h), or to have associated with
high endothelial venules, indicating a lack of direct bacterial entry
or exit through blood vessels in early infection. Even 24 h after
infection, streptococci in ipsilateral axillary lymph nodes were
predominantly seen in subcapsular sinuses, although an associa-
tion with high endothelial venules was evident at this time point
within non-draining lymph nodes, indicative of bloodstream
spread (Supplementary Fig. 4a, b).
Bacterial virulence factors determine extent and consequences
of lymphatic-dissemination. In principle, the small dimensions
of bacteria alone might be sufficient to permit passive dis-
semination via lymphatic channels. To determine whether the
process depended on the active involvement of bacterial virulence
mechanisms, we evaluated a panel of isogenic S. pyogenes strains.
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Fig. 2 S. pyogenes transit to and between lymph nodes in lymphatic vessels. a Schematic of imaging area. b–h Intravital microscopy images of the
efferent lymphatic vessel that connects the inguinal and axillary lymph nodes in mice. S. pyogenes (green), lymph (blue) and blood vessels (black). FVB/n
mice infected intramuscularly with 108 CFU of hypervirulent S. pyogenes (H1565), either unlabelled (b, c) or fluorescently labelled (e–h) and imaged within
1 h. Scale bars: 100 µm (b, e); 10 µm (c, d, f–i). i Three-dimensional reconstruction of fluorescently labelled streptococci adhered to leukocyte cell surface,
scale bar 5 µm. Data are representative of four independent experiments. See also Supplementary Fig. 3 and Supplementary Movies 1–5.
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Fig. 3 S. pyogenes are confined to sinuses within lymph nodes. a–h Immunofluorescence staining of local draining inguinal (a–d) and distant draining
axillary (e–h) lymph node cryosections from FVB/n mice prepared 3 h after intramuscular injection into the hindlimb with 108 CFU of hypervirulent S.
pyogenes (H1565); stained for S. pyogenes (green), podoplanin (red) and with DAPI (blue). White arrows highlight the location of S. pyogenes. Podoplanin
staining highlights lymphatic endothelial cells in the subcapsular and medullary sinuses, as well as fibroblastic reticular cells in the cortex of the lymph
node. Scale bars: 200 µm (a, e); 20 µm (b–d, f–h). Data are representative of five independent experiments. See also Supplementary Fig. 4a, b, and
Supplementary Movies 6 and 7.
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Invasive streptococcal isolates that cause severe systemic infec-
tions, such as those used in our study, frequently carry mutations
in the bacterial two-component regulatory system CovR/S (also
known as CsrRS)30–32, which de-repress virulence factors that
promote invasiveness, including hyaluronan capsule and the
chemokine-cleaving protease, SpyCEP33. We compared the in
vivo-passaged hypervirulent strain H1565, which has a CovR
mutation and therefore produces abundant capsule (high-capsule
CovRmutant), with its parent clinical M1T1 strain H584 (wildtype)
in a 24-h time course infection. We further compared these
strains with additional isogenic derivatives of H584 that either
lacked capsule (Δcapsule, H1454), or produced abundant capsule
(high-capsule ΔP2, H1458), due to a specific mutation in the
capsule synthesis promoter34 (Supplementary Table 1). While
bacterial counts at the injection site were similar for all strains
throughout infection, and all strains exhibited some lymphatic
dissemination, the two high-capsule strains exhibited a particular
propensity for lymphatic dissemination and also had greater
bacterial loads in systemic organs during the first 3 h of infection
than wildtype and acapsular strains (Fig. 4a, b), confirming a
specific role for S. pyogenes hyaluronan capsule in bacterial
lymphatic tropism and retention. Abrogating LYVE-1-mediated
retention of hyaluronan-expressing S. pyogenes within the lym-
phatic system12, using a LYVE-1 hyaluronan blocking antibody23,
significantly reduced bacterial numbers in both the local draining
inguinal and distant draining axillary lymph nodes, but simul-
taneously augmented the entry of bacteria into the bloodstream,
spleen and liver (Supplementary Fig. 4c–e). Hence, functional
blockade of LYVE-1 allows S. pyogenes that reach the draining
lymph node to more readily transit along lymphatic vessels,
through lymph nodes and into the bloodstream. By 24 h post-
injection, infections with the high-capsule CovRmutant strain had
progressed to a much higher systemic bacterial load than high-
capsule ΔP2 strain and featured more prominent seeding of non-
draining lymph nodes than all the other strains (Fig. 4c). These
data pointed to a role for further CovR/S-regulated virulence
factors, in addition to the hyaluronan capsule, that enable the
subsequent expansion of bacterial numbers within lymph node
infection metastases and drive development of systemic disease.
S. pyogenes subvert recruitment of neutrophils to aid survival
within lymph nodes. Neutrophils are rapidly recruited to infected
tissues and the local draining lymph node in response to an
assortment of chemoattractants produced by various cells in
inflamed tissues5,35,36. Having identified a key role for CovR/S-
mediated virulence in the expansion of S. pyogenes within lymph
node metastases, we hypothesised that the CovR/S-regulated
chemokine-cleaving protease, SpyCEP, which can inhibit
neutrophil-recruitment to an infection site24,37 might play a role
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way ANOVA followed by Tukey’s multiple comparisons post-tests were performed on log10-transformed data. CFU are per ml of blood, per g of liver, per
leg, or per organ.
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-18454-0 ARTICLE
NATURE COMMUNICATIONS |         (2020) 11:4697 | https://doi.org/10.1038/s41467-020-18454-0 | www.nature.com/naturecommunications 5
in survival and expansion of S. pyogenes within lymph nodes. To
determine if SpyCEP-mediated subversion of neutrophil-
recruitment might underpin the ability of hypervirulent S. pyo-
genes to spread within the lymphatic system, we generated a
ΔSpyCEP mutant (H1567) from the hypervirulent strain H1565
and measured numbers of bacteria and neutrophils in lymph
nodes following hindlimb infection. Compared to its parent strain
H1565, infection with the ΔSpyCEP mutant yielded a 100-fold
and 20-fold reduction in bacterial counts in draining ipsilateral
inguinal and sequential axillary lymph nodes respectively, despite
no significant change in CFU at the infection site at the early 3 h
time point (Fig. 5a). Infection with the ΔSpyCEP mutant also
resulted in 50-fold higher relative neutrophil numbers (live
CD45+, CD11b+, Ly6G+ cells) in draining lymph nodes com-
pared to the virulent strain and 10-fold lower neutrophil counts
in blood (Fig. 5b), consistent with a major role for the chemokine
CXCL8 (CXCL1/2 in mice) in neutrophil recruitment to the
lymph node36. Additionally, fluorescent immunostaining revealed
only limited phagocytosis of hypervirulent S. pyogenes H1565 by
neutrophils in lymph nodes (Fig. 5c, d). By 24 h post-infection,
extensive prominent foci of invading bacteria were evident deeper
in the lymph node parenchyma, often forming large extended
necrotic regions (Fig. 5e and Supplementary Movie 8). In these
areas, diffuse nucleic acid staining demonstrated significant lysis
of cells, including neutrophils (Fig. 5f). Where S. pyogenes had
expanded into deeper sinuses further into the parenchyma of
draining lymph nodes, there was a relative paucity of recruited
neutrophils in comparison with the subcapsular sinus (Fig. 5g, h),
suggesting that invading bacteria may be partly sheltered from the
immune response due to the architecture of the lymph node
impeding cellular recruitment. The hypervirulent S. pyogenes
strain used in these experiments is inherently more resistant to
phagocytosis by neutrophils than wild type S. pyogenes, expres-
sing factors other than SpyCEP that impair phagocytic clearance,
including capsule (Supplementary Fig 5a). Both SpyCEP+ and
ΔSpyCEP S. pyogenes were able to multiply in lymph nodes over
24 h despite the ratio of bacteria to neutrophils remaining visibly
higher in mice infected with the SpyCEP+ strain (Supplementary
Fig. 5b–g). Confocal microscopy revealed that most of these
bacteria were extracellular (Supplementary Fig. 5h). However,
isolation of the role of SpyCEP through heterologous expression
of SpyCEP in Lactococcus lactis (an avirulent bacterium that is
readily phagocytosed), revealed that SpyCEP drove systemic
infection in mice, dramatically increasing bacterial burden in
draining lymph nodes and systemic organs (Supplementary
Fig. 5i). We conclude that the CovR/S-regulated virulence factor
SpyCEP compromises recruitment of neutrophils to help drive
progression of infection in draining lymph nodes, although
additional CovR/S factors also promote bacterial replication and
survival.
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S. pyogenes is extracellular within lymph nodes and evades
killing by CD169+ macrophages. The lymph node sinuses,
where we observed metastatic S. pyogenes to accumulate during
infection, are lined with CD169+ macrophages, including subsets
well-recognised for capture of certain viruses and restriction of
viral systemic dissemination38–40. However, our data showed that
many streptococci transit through sequential lymph nodes,
apparently unhindered by this population of macrophages. We
investigated this interaction using confocal microscopy, which
showed that 3 h after infection with a hypervirulent strain
(H1565), S. pyogenes were neither sequestered nor internalised by
CD169+ cells, with only extremely rare instances of colocalization
(Fig. 6a–c, Supplementary Movie 9). Furthermore, depletion of all
lymph-borne macrophages with clodronate liposomes (Supple-
mentary Fig 6a, b) prior to infection with S. pyogenes had no
effect on either lymph node or systemic bacterial counts
(Fig. 6d–f). Gentamicin protection assays performed on single-
cell suspensions of lymph nodes (Fig. 6g, h) also showed that
bacteria within lymph nodes were overwhelmingly extracellular
throughout the infection time course. In co-culture, M1T1
wildtype H598 and otherwise isogenic highly encapsulated ΔP2
and CovRmutant strains showed only limited internalisation by
murine bone marrow-derived macrophages (Supplementary
Fig. 6c, d). Moreover, these bacteria all induced significant mac-
rophage cell death (Supplementary Fig. 6e), supporting the
observation that lymph node macrophages are ineffective in
controlling S. pyogenes in vivo.
Discussion
Thorough understanding of the route taken by extracellular
bacteria from an extravascular site of infection into the blood-
stream is currently lacking. Severe bloodstream infection
is commonly believed to arise after invasion of blood vessel
endothelium by bacteria at the site of local infection. However,
the incidence of devastating metastatic infections that lack a clear
portal of entry, such as those caused by S. pyogenes41,42, is indi-
cative that other routes of entry may be important, and under-
lines the need for more comprehensive investigation of the issue.
In this article, we have revealed that extracellular lymphatic
metastasis is a major mechanism of systemic dissemination in S.
pyogenes infection, demonstrating that the lymphatics serve as
both a survival niche and a preferential conduit to reach the
bloodstream for S. pyogenes.
In humans, common manifestations of S. pyogenes infections,
such as streptococcal tonsillitis and pharyngitis, are well-recognised
to lead to lymphadenitis11,43 and S. pyogenes DNA can be found in
the lymph nodes of such patients44. We propose that metastatic
bacterial spread to and, crucially, through draining lymph nodes
during infections of the upper respiratory tract and tonsils, or other
sites, provides an explanation for the phenomenon of occult bac-
teraemia and distant infection related to seemingly innocuous or
non-invasive infections that lack an apparent portal of entry41,42.
Notably, lymphatic metastasis was enhanced in hypervirulent iso-
lates of S. pyogenes that are associated with severe clinical outcomes,
implying its importance in human streptococcal disease. In these
hypervirulent strains, we found that elevated expression of hya-
luronan capsule (historically described as hyaluronic acid or hya-
luronate capsule) and SpyCEP, augmented by mutations in the
CovR/S regulatory system, increased bacterial burden within the
lymphatic system in experimental disease. However, invasive S.
pyogenes infections are rare and patently the lymphatic metastasis
of bacteria does not routinely allow every trivial infection to
develop into a serious systemic disease. The exact circumstances
under which lymphatic metastasis can drive fatal S. pyogenes
infection in humans remain undefined, but would be expected to
involve a combination of host and environmental factors, including
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Fig. 6 S. pyogenes is extracellular within lymph nodes and evades killing by CD169+ macrophages. a–c Immunofluorescence staining of cryosections
from the draining inguinal lymph nodes of FVB/n mice 3 h after intramuscular injection into the hindlimb with 108 CFU of hypervirulent S. pyogenes H1565
(green); CD169 (blue) and brightfield shown in grey; Overview of the subcapsular sinus (SCS) and medullary sinuses (MS) (a); Maximum intensity
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experiments. See also Supplementary Movie 8. d–f Recovery of S. pyogenes H1565 from the hindlimb infection site (d), draining lymph nodes (e), and
systemic organs (f) of FVB/n mice injected subcutaneously in the tail and leg with either clodronate liposomes (red triangles), saline liposomes (blue
squares), or a saline sham (grey circles) 96 h prior to a 3-h intramuscular infection with 108 CFU. Symbols represent individual mice, n= 5 per group, lines
indicate geometric means. ns, p > 0.5: one-way ANOVA followed by Tukey’s multiple comparisons post-tests were performed on log10-transformed data.
g, h Percentage of intracellular S. pyogenes 0.5, 3, or 24 h after intramuscular infection with 108 CFU of S. pyogenes H1565; gentamicin protection assays on
ipsilateral inguinal nodes (g) or spleens (h) of infected FVB/n mice at each time point. Each red circle represents an individual mouse, n= 5 per group,
black lines indicate geometric means. See also Supplementary Fig. 6. CFU are per ml of blood, per leg, or per organ.
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underlying medical conditions45, prior injury34,46, level of exposure
to S. pyogenes47 and host genetic factors48–50, as well as strain-
specific virulence.
Beyond invasive disease, our data showed that S. pyogenes
strains of lesser virulence could also reach and persist within
lymph nodes, but without driving development of intense bac-
teraemia. Presence of bacteria in lymph nodes and the resulting
inflammation has been shown to disrupt immune responses51–53.
S. pyogenes, additionally, can secrete immune-dysregulating
proteins termed superantigens that activate T cells in an uncon-
trolled manner54 to disrupt immune responses in lymphoid
tissue55,56. Bacterial lymphatic metastasis may contribute to
recurrent childhood streptococcal infections57 by slowing natural
development of protective immunity57. Moreover, heavily
encapsulated S. pyogenes isolates are associated with the auto-
immune disease rheumatic fever58; strong lymphatic-retention of
these strains mediated in part by hyaluronan capsule-mediated
sequestration by LYVE-1, as demonstrated here, could provide a
persistent stimulus that may lead to development of auto-
immunity, driven in part by superantigens. Additionally, the
observed interaction between streptococci and lymphocytes
within the efferent lymphatics, possibly mediated through bac-
terial adhesion to CD4459, could be anticipated to have con-
sequences for immunity. Nevertheless, there is also potential for
therapeutic exploitation of lymphatic bacterial homing, through
heterologous expression of hyaluronan capsule in bacterial vac-
cine vectors to enhance antigen delivery to lymph nodes.
A small number of recent studies have shown that injected
bacteria that do reach the local draining lymph node are con-
strained by immune responses and either reported that the bac-
teria did not reach sequential draining lymph nodes or did not
investigate them5,35,53. Although some of our observations may
be specific to the strain of mouse or specific hypervirulent strains
used, our experiments with S. pyogenes found lymphatic metas-
tasis to occur in several common strains of mouse, and in several
different clinically relevant isolates. Experimental ablation of
innate immune cells in lymph nodes has been demonstrated to
increase systemic burden for some bacteria, although these stu-
dies did not characterise the route of spread5,35. CD169+ sub-
capsular and medullary sinus macrophages are strategically
positioned in lymph nodes and can prevent systemic spread of
certain viruses38,39. Though a similar role has been suggested in
bacterial elimination, the data are less clear5,35. S. pneumoniae has
recently been reported to replicate inside analogous spleen
CD169+ macrophages60 and our results further temper the sig-
nificance of CD169+ macrophages in controlling dissemination
of virulent bacteria. Contrasting with intracellular replication of S.
pneumoniae observed in the spleen60, we observed that encap-
sulated hypervirulent S. pyogenes were not sequestered by lymph
node macrophages, but instead replicated extracellularly. Neu-
trophils are recruited to local draining lymph nodes close to an
initial infection site and play a vital role in combating bacterial
infection5,35,61. We found that, in addition to local draining
lymph nodes, large numbers of neutrophils were also recruited to
distant draining lymph nodes far from the initial infection site. S.
pyogenes was able to undermine this response by resisting pha-
gocytosis and impairing neutrophil-recruitment through pro-
duction of the chemokine-cleaving protease, SpyCEP, a finding
that supports a key role for the chemokine CXCL8 (CXCL1/2 in
mice) in directing neutrophil migration36 towards live bacteria
within lymph nodes. Thus, in the case of virulent S. pyogenes,
neither neutrophils nor macrophages can contain bacterial
infection effectively within lymph nodes.
While S. pyogenes is unique in the extent of its association with
bacterial lymphangitis and lymphadenitis in humans, other spe-
cies of bacteria have been recovered from lymph nodes in patients
undergoing surgery62–64, with some evidence that lymph nodes
may serve as a route of bacterial dissemination65. Hyaluronan, in
addition to mediating specific binding to lymphatic vessels, is a
large polyanionic and hygroscopic molecule that can serve to
mask underlying adhesion molecules on the bacterial surface66,67,
inhibit phagocytic clearance68 and increase electrostatic repulsion
in the extracellular matrix69: features that enhance the uptake of
particles into lymphatic vessels70,71. Many other bacterial species
produce exopolysaccharides (including capsules), which can
confer similar non-specific physical properties to those of hya-
luronan. Additionally, as most bacteria are of a size that permits
passive lymphatic transport, lymphatic metastasis could be per-
tinent to the pathogenesis of other bacterial species.
Earlier investigators provided evidence that bacteria were
capable of passage through the lymphatics72, but these studies did
not address the resulting impact on the development of infection,
and technical aspects of their work have been queried73. Fur-
thermore, more direct routes of bloodstream invasion have been
reported for extracellular bacteria in different models73–75.
Recently, elucidation of a multitude of bacterial cellular-invasion
mechanisms75–77, often involving intracellular survival, has fur-
ther shifted focus away from the role of the lymphatics in
extracellular bacterial dissemination. As such, contemporary
research on translocation of bacteria in the lymphatics has
focused on the concept of Trojan horses: migrating phagocytes
that carry internalised, but viable, bacteria8,78. The findings
herein unequivocally establish that S. pyogenes remains extra-
cellular while disseminating from a local site of infection through
multiple sequential draining lymph nodes to reach the
bloodstream via efferent postnodal lymphatic vessels. Notwith-
standing any immediate relevance to streptococcal diseases,
the propagation of bacteria within the lymphatic system has
broad relevance to host-pathogen interactions and immunity.
The results of this study, demonstrating the importance and
mechanisms of bacterial lymphatic metastasis, prompt reconsi-
deration of currently understood paradigms of bacterial dis-
semination and pathogenesis.
Methods
Bacterial strains and growth conditions. Streptococcus pyogenes (Supplementary
Table 1) was cultured on Columbia horse blood agar (CBA) (EO Labs) or in Todd
Hewitt broth with yeast extract (both Oxoid) at 37 °C, in 5% CO2. Lactococcus lactis
were grown on CBA at 30 °C in air. For mutagenesis protocols, LB media (Oxoid)
were used to grow Escherichia coli at 37 °C in air. Growth media were supple-
mented with 50 μg/ml kanamycin for selection and maintenance of pUCMUT-
containing E. coli and 400 μg/ml kanamycin for selection of gene-disruption S.
pyogenes mutants. Previously derived SpyCEP expression vector pCepA79 or empty
vector control pDestErm were maintained in L. lactis with 5 µg/ml erythromycin.
Construction of S. pyogenes gene-disruption mutants. A S. pyogenes hyaluronan
capsule knockout mutant (H1454) of isolate H584 was constructed by disruption of
hasA and hasB using the suicide vector pUCMUT80,81. A 500 bp fragment of the 5′
hasA gene was amplified (forward primer: 5′- GGGGTACCTATCTTGATTTAT
CTAAATATG-3′, reverse primer: 5′- GGAATTCGTTTCTAGCATTCAAATGTC
CT-3′) incorporating EcoRI and KpnI restriction sites into the 5′ and 3′ ends
respectively, and a 500 bp fragment of the 3′ hasB gene was amplified (forward
primer: 5′-ACGCGTCGACATGATGATCGAATAGGAATGC-3′, reverse primer:
5′- AACTGCAGCAATCATACCACCAACTGCAG-3′) incorporating PstI and SalI
restriction sites into the 5′ and 3′ ends respectively, and cloned into digested
pUCMUT either side of the aph3 kanamycin resistance gene. The construct was
introduced into S. pyogenes by electroporation and crossed into the chromosome
by homologous recombination. PCR analysis demonstrated a double recombina-
tion event between chromosomal hasA and hasB and the corresponding 500 bp
fragments which abrogated production of hyaluronan capsule. To construct a
SpyCEP allelic replacement mutant (H1567), in hypervirulent strain H1565, a 520
bp fragment of the cepA gene and a 485 bp fragment of the intergenic region
between cepA and hypothetical protein M5005_Spy0343 were amplified and cloned
into the suicide vector pUCMUT81 to produce pUCMUTcepA using appropriate
sequential restriction enzymes (forward primer: 5′-ATAGCGAATTCAACAGA-
CAAAAACCTCCGCT -3′, reverse primer: 5′-ATAGGGTACCTTGTGATTGCT
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CTTTTTCACGA-3′, incorporating EcoRI and KpnI restriction sites into 5′ and 3′
ends, respectively, and forward primer:
5′-AGACGTCGACCAAAGCGCAAAGCGACAACAAA-3′, reverse primer:
5′-ATAGCTGCAGAACTGGGGGTGTCTCCGT-3′, incorporating SalI and
PstI restriction sites into the 5′ and 3′ ends). Plasmids were propagated in E. coli
XL-10 gold (Agilent) and the construct electroporated into S. pyogenes H1565 and
inserted into the chromosome by homologous recombination. PCR analysis
demonstrated a double recombination event between chromosomal cepA and the
520 bp and 485 bp fragment. The allelic replacement fully negated CXCL8 cleavage
activity and production of SpyCEP, measured by CXCL8 cleavage assays and
western blots, respectively.
Mouse-passaged derivatives of S. pyogenes H584. Derivatives of H584 with a
mutation in the CovR binding site of the hyaluronan capsule promoter P2 (H1458)
that resulted in elevated hyaluronan, or a covR mutation (H1565) were recovered
from a lymph node and spleen respectively after one in vivo passage and have been
previously defined34.
Mice. In vivo experiments were performed in accordance with the Animal (Sci-
entific Procedures) Act 1986, with appropriate UK Home Office licenses according
to established institutional guidelines using 4–10-week-old FVB/n, or where stated
BALB/c and C57BL/6 female mice (Charles River UK). Mice were housed in
standard conditions, with an ambient temperature of 21 °C, 50% humidity and a
12-h light cycle.
Analysis of lymphatic drainage. Mice were injected intramuscularly into the
hindlimb with 50 µl of 1% Evans blue dye in PBS, which highlights draining
lymphatic vessels and lymph nodes. After 30 min, mice were euthanised, dissected,
and photographed.
Infections. Mice were challenged intramuscularly with 104–108 CFU of S. pyogenes
in 50 µl PBS and quantitative endpoints compared at 0.5, 3, or 24 h post-infection.
To maintain SpyCEP expression vector pcepA and empty vector control pDestErm
in L. lactis in vivo, both groups of L. lactis-infected mice were given 100 µl of 100
µg/ml erythromycin intraperitoneally 4 h before infection.
Enumeration of bacteria from organs and blood. At specified endpoints, mice
were anaesthetised with isoflurane (4% induction, 2% maintenance), blood taken
by cardiac puncture into tubes containing heparin, then euthanised. Thigh muscle,
liver, spleen, and ipsilateral and contralateral axillary, brachial, iliac, and inguinal
lymph nodes were dissected for further analyses. Dissected lymph nodes were first
disrupted with a motorised pellet pestle, and all organs and tissues were homo-
genised with scissors in PBS. Bacterial CFU counts were determined by plating of
homogenised tissue and blood samples onto the specified agar, with or without
dilution in PBS, as appropriate. CFU are displayed as per ml of blood, per g of
liver, per leg, or per organ for all figures.
Preparation of single-cell suspensions from organs. Dissected lymph nodes
were disrupted with a motorised pellet pestle and then chopped further with
scissors. Dissected spleens were minced with scissors. Lymph node and spleen
fragments were then digested for 20 minutes at 37 °C with 200 U/ml collagenase IV
and 100 U/ml DNase I (both Worthington Biochemical Corp) in digestion buffer
(HBSS with 0.5% BSA, 2 mM Ca2+ and 10 mM HEPES). Spleens were next passed
through a 100 µm cell strainer in cell buffer (HBSS with 2 mM EDTA, 0.5% BSA,
and 10 mM HEPES) containing 100 U/ml DNase I. For lymph nodes, large tissue
fragments were allowed to settle and the supernatant, which contained the cells of
interest, was removed and the cells washed before resuspension in cell buffer. If
required, erythrocytes in spleen suspensions and blood were lysed with BD Pharm
Lyse (BD Biosciences). If bacteria were to be maintained in the sample, a high-
speed spin (10,000×g) of supernatants was performed after mouse cells were
removed with a lower speed spin (400×g) and the two fractions subsequently
recombined.
Ex vivo gentamicin protection assays. Single-cell suspensions from the organs of
mice infected with S. pyogenes were incubated with or without 100 µg/ml of gen-
tamicin in HBSS (with 10 mM HEPES) for 1 h at 37 °C in 5% CO2. Cells and any
bacteria were then washed to remove residual antibiotic, using the two-step cen-
trifugation approach described above, and the mouse cell and bacterial fractions
recombined. Samples were then resuspended in pH 11 H2O, to efficiently lyse
murine cells82, and plated on CBA with dilution where required. CFU counts from
gentamicin-treated samples were compared with untreated samples to calculate the
percentage of intracellular bacteria. Alternatively, the assay was performed with
immortalised bone-marrow-derived macrophages following a 3-h incubation with
S. pyogenes.
Flow cytometry on in vivo cell infiltrate. Single-cell suspensions from the organs
and blood of mice were resuspended in PBS and stained with Zombie NIR Viability
dye (BioLegend). Cells were then washed and resuspended in staining buffer (HBSS
with 2 mM EDTA, 0.5% BSA, and 5% rat serum) with a saturating concentration of
anti-CD16/32 (93) and stained with anti-CD45-PerCP-Cy5.5 (30-F11), anti-
CD11b-APC (M1/70), and anti-Ly6-G-PE (1A8) (all BioLegend). In other
experiments, anti-CD11c-FITC (N418) (BioLegend), anti-CD169-PE (REA197)
and anti-F4/80-FITC (REA126) (both Miltenyi Biotec) were used. Samples were
analysed on an Attune NxT flow cytometer using Attune NxT software (Thermo
Fisher). Cells were gated to determine live singlets, and neutrophils were defined as
CD45+, CD11b+ and Ly6G+.
LYVE-1 functional blockade. For LYVE-1 function blocking experiments, mice
were injected intraperitoneally with 500 µg anti-LYVE-1 (mAb2125) or control rat
IgG (both R&D) 24 h prior to intramuscular infection with S. pyogenes.
Macrophage depletion. To deplete macrophages in lymph nodes draining the
infection site, mice were injected subcutaneously with 200 µl clodronate liposomes
(7 mg/ml clodronate disodium), or the same volume of control PBS-liposomes
(both FormuMax), or PBS. Injections were distributed between the tail (40 µl) and
leg regions (160 µl), which drain to the inguinal lymph node, and performed 96 h
prior to intramuscular infection with S. pyogenes.
Macrophage culture. Immortalised bone marrow-derived macrophages (iBMDM)
were cultured in complete media (DMEM, with 10% FBS and 10 mM HEPES) at
37 °C in 5% CO2. Prior to bacterial assays, macrophages were seeded near con-
fluency onto tissue-culture treated multi-well plates and incubated overnight,
before complete media was changed for warm HBSS (with Mg2+ and Ca2+ and 10
mM HEPES) to prevent bacterial growth during assays.
Macrophage gentamicin protection assay. S. pyogenes in HBSS was added to
iBMDM adhered to tissue-culture treated multi-well plates at an MOI of 10:1.
Plates were spun for 3 min at 500×g to synchronise infection and then incubated at
37 °C in 5% CO2 for 3 h. The macrophage layer was then gently washed four times
with warm PBS (with Mg2+ and Ca2+), before the addition of 100 µg/ml of gen-
tamicin in HBSS for 1 h at 37 °C in 5% CO2. Wells were again gently washed four
times with warm PBS (with Mg2+ and Ca2+) to dilute the antibiotic and the
macrophages were detached with Accutase (BioLegend) and lysed with 0.025%
Triton X-100. Lysates were serially diluted in PBS and plated on CBA to measure
intracellular CFU.
Macrophage phagocytosis and viability assay. S. pyogenes was stained with 10
µM Oregon Green 488-X, Succinimidyl Ester (Invitrogen) and added to iBMDM,
prepared as above at an MOI of 10:1. Plates were spun for 3 minutes at 500×g to
synchronise infection and then incubated at 37 °C in 5% CO2 for 3 h. The mac-
rophage layer was gently washed five times with warm PBS (with Mg2+ and Ca2+)
to remove non-cell-associated S. pyogenes and then cells were detached with
Accutase (BioLegend). Cells were resuspended in cold PBS with 2 mM EDTA and
transferred to low-bind 96-well plates for staining with Zombie NIR Fixable Via-
bility Dye (BioLegend). Macrophages were analysed using a Cytoflex flow cyt-
ometer using CytExpert (Beckman Coulter) and FlowJo (BD) for cell-associated
and internalised S. pyogenes. Unstained S. pyogenes controls were used for gating,
and a final concentration of 0.2% Trypan Blue or 25 µg/ml Ethidium Bromide,
added two minutes before acquisition, was used to determine intracellular bacteria
by quenching and/or Förster resonance energy transfer (FRET) of fluorescence
from extracellular bacteria.
Neutrophil phagocytosis assay. Fresh human neutrophils were acquired from an
approved subcollection of normal healthy donor blood samples of the Imperial
College London Tissue Bank; all volunteers gave informed consent. Neutrophils
were isolated from heparinised human blood using a MACSXpress Whole Blood
Neutrophil Isolation Kit (Miltenyi Biotec) and resuspened in HBSS to 2 × 106 cells/
ml. S. pyogenes was stained with 10 µM Oregon Green as above and added to
neutrophils at an MOI of 10:1. Tubes were incubated at 37 °C with end-over-end
mixing for 30 min. The reaction was stopped with an excess of cold PBS (with 5
mM EDTA) and cells were analysed on a FACSCalibur using BD CellQuest Pro
(BD Biosciences) and FlowJo (BD). Controls using unstained S. pyogenes were used
to set gating and a final concentration of 0.2% Trypan Blue added immediately
prior to acquisition was determine intracellular bacteria by quenching and/or FRET
of fluorescence from extracellular bacteria.
Intravital imaging. S. pyogenes were resuspended to an OD600 of 10 (~5 × 109
CFU/ml) in PBS, stained with far-red fluorescent DNA dye, SYTO 62 (final con-
centration 5 µM), and washed in PBS. In all, 4–6-week-old mice were infected
intramuscularly with 108 CFU of either unlabelled or fluorescently labelled bacteria
and, following a holding period of 30 min, underwent deep terminal anaesthesia
using a cocktail of ketamine (Ketamidor) and medetomidine (Domitor) injected
intraperitoneally or subcutaneously. Mice were maintained at 37 °C on an electric
heat-pad, and hair on the leg and flank was removed with an electric shaver and
depilation cream. In all, 40 µl FITC-conjugated 2000 kDa dextran (2.5 mg/ml) was
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injected subcutaneously into the tail and, in pilot experiments, 100 µl TRITC-
conjugated 155 kDA dextran (2.5 mg/ml) (both Sigma) was injected intravenously.
Intramuscular injection of SYTO 62 dye alone into the hindlimb did not stain host
cells in the inguinal postnodal lymphatic, and injection of SYTO 62-stained S.
pyogenes that did not reach the axillary node (H1454) showed no signal in the
postnodal lymphatic (Supplementary Fig. 3d, e). Direct staining of host cells with
SYTO 62 resulted in bright staining of the nucleus only, similar to DAPI (Sup-
plementary Fig. 3f, g). For labelling of cells in efferent lymph, desired combinations
of 5 µg of anti-B220 Brilliant Violet 421 (RA3-6B2), anti-CD3-PE (145-2C11), anti-
CD11b-Alexa Fluor 488 (M1/70), anti-F4/80- Brilliant Violet 421 (BM8) (all
BioLegend) and 100 µg Hoechst 33342 (Thermo Scientific) were injected sub-
cutaneously into the tail. For imaging, anaesthetised mice were placed in a supine
position and a vertical incision was made in the skin along the midline, extended
laterally at the inguinal and axillary regions to create a skin flap. Mice were then
moved into a prone position with the skin flap flat against a stage plate insert with
central coverslip window. A piece of wood doweling was placed against the body of
the mouse to help hold the skin flat and reduce the impact of breathing artifact
during imaging (Supplementary Fig. 3b). Mice were transferred to the microscope
stage and maintained at 37 °C in an incubation chamber (Life Imaging Services)
throughout imaging. Isoflurane administered when required and mice were
euthanised once imaging was finished. Light was generated from 405-nm, 488-nm,
561-nm, 594-nm and 633-nm lasers, as appropriate. Emitted light signal was
detected using either a 10×/0.3, 20×/0.5, 25×/0.95, or 40×/1.1 objective lens, as
required, using a Leica SP5 confocal microscope. Images were processed using LAS
X (Leica) and ImageJ2.
Immunofluorescence microscopy. Lymph nodes were either fresh snap-frozen or
fixed in 2% paraformaldehyde in PBS, followed by protection in 30% sucrose in
PBS before snap-freezing. 6–15 µm frozen sections were cut using a cryostat, dried,
fixed in cold acetone (-20 °C) for 5 min, and then blocked (5% FBS, 5% goat serum,
5% rat serum, and 0.5% BSA in PBS). When required, an avidin/biotin blocking
system was used (BioLegend). Sections were then stained, as required, with com-
binations of anti-Ly6G-AF594 (1A8), anti-CD169-AF647 (3D6.112), biotinylated
anti-PNAd-biotin (MECA-79) (all BioLegend), hamster anti-podoplanin (8.1.1)
(eBioscience), anti-LYVE-1-eFluor 570 (ALY7) (Invitrogen), and anti-Group A
Carbohydrate-FITC (9191) (Abcam) in staining buffer (blocking buffer with 0.05%
Tween-20) for 1 h. Next, if required, slides were incubated with anti-hamster IgG-
AF647 and Streptavidin-AF546 (both Invitrogen) in staining buffer for 45 minutes.
Nuclei were counterstained with DAPI and sections mounted with ProLong Gold
(both Invitrogen). Light was generated from 405-nm, 488-nm, 561-nm, 594-nm,
and 633-nm lasers as required, and emitted light signal detected using either a 10×/
0.3 or 20×/0.7 objective on a Leica SP5 confocal microscope. Tiled scans were
performed to image entire lymph node sections and areas of special interest were
imaged with a 40×/1.3 or 63×/1.4 objective. Mosaic images were generated from
tiled stacks using LAS X (Leica) and zoom and panning videos of mosaic images
generated using the IC FILM Zoom and Pan macro in ImageJ2. Orthogonal views
and projections of confocal z-stacks were also constructed in ImageJ2.
Statistics. All statistical analyses were performed with GraphPad Prism 8.4.
Comparison of two datasets was carried out using a two-tailed Student’s t-test on
log10-transformed data or a two-tailed Mann–Whitney U test. For comparison of
three or more data sets, one-way ANOVA followed by Tukey’s multiple compar-
isons post-tests were performed on log10-transformed data. A p-value of ≤ 0.05 was
considered significant.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Source data are provided with this paper. Further data that support the findings of this
study are available from the corresponding authors upon reasonable request.
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